Matthew Hebb, MD, PhD, FRCSC
Associate Professor of Neurosurgery, Western University
Office: London Health Sciences Centre, University Hospital C7-134
Secretary: Cheryl Johnson
Dr. Hebb holds BSc degrees in both Biology and Mathematics from Dalhousie University. He attained his PhD from Dalhousie in Pharmacology and Neuroscience in 1998. Dr. Hebb attained his MD from the University of Toronto in 2002 before completing his Neurosurgery residency training at Dalhousie University and a fellowship in neurosurgery and Skullbase surgery at the Barrow Neurological Institute under Robert Spetzler in Phoenix Arizona.
Dr. Hebb joined the Department in 2009 specializing in glial biology/neuro-oncology , and movement disorders. In addition to his position with CNS, Dr. Hebb is also an Associate Professor of Neuroscience, an Associate Professor of Anatomy and Cell Biology, an Associate Professor of School of Graduate and Postdoctoral Studies, an Associate Professor of Otolaryngology and Head & Neck Surgery, and an Associate Professor of Department of Oncology.
He is a Fellow of the International Parkinson and Movement Disorders Society, the North American Skull Base Society, The Congress of Neurological Surgeons, RCPSC, the American College of Surgeons, and the American Association of Neurological Surgeons. He is a member of the Society for Neuroscience, the Society for Neruo-Oncology, the Canadian Neurological Sciences Federation, the Ontario Medical Association, and the Canadian Medical Association.
Dr. Hebb is currently leading a Working Group in Glioblastoma. This is a new research initiative lead by Dr. Hebb and Dr John Ronald to establish an investigator network from Western University, Robarts Research Institute, LHRI and external academic centres in the pursuit of collaborative pilot studies leading to long-term group research projects related to malignant glioma.
He is also the lead investigator on a number of collaborative studies on neuro-oncology and neurodegenerative disease.
Neuro-oncology, Movement Disorder Surgery, Parkinson's Disease Surgery, Tumour Surgery, Skull Base Tumours
Honours and Awards
- 2016, Vanguard Innovation Award, WORLDiscoveries Western University
- 2008, Dr. W.D. Stevenson Research Award, Dalhousie University
- 2006, Dr. W.D. Stevenson Research Award, Dalhousie University
- 2006, Killam Memorial Scholarship, Dalhousie University
Staudt MD, Di Sebastiano AR, Xu H, Jog M, Schmid S, Foster P, Hebb MO. Advances in Neurotrophic Factor and Cell-Based Therapies for Parkinson's Disease: A Mini-Review. Gerontology. 2016;62(3):371-80. doi: 10.1159/000438701. Epub 2015 Sep 1. Review. PubMed PMID: 26330171.
Belkacemi L, Hebb MO. HSP27 knockdown produces synergistic induction of apoptosis by HSP90 and kinase inhibitors in glioblastoma multiforme. Anticancer Res. 2014 Sep;34(9):4915-27. PubMed PMID: 25202074.
Bharadwaj S, Haji F, Hebb M, Chui J. Direct motor evoked potentials and cortical mapping using the NIM® nerve monitoring system: A technical note. J Clin Neurosci. 2017 Apr;38:111-113. doi: 10.1016/j.jocn.2016.11.006. Epub 2016 Dec 22. PubMed PMID: 28017534.
Xu HU, Bihari F, Whitehead S, Wong E, Schmid S, Hebb MO. In Vitro Validation of Intratumoral Modulation Therapy for Glioblastoma. Anticancer Res. 2016 Jan;36(1):71-80. PubMed PMID: 26722029.
- Canadian researchers grow cells from brain tissue; could help treat Parkinson's - CTV News
- Biopsied brain tissue yields regenerative cells — potential Parkinson’s therapy? - Global News